HOME > LATEST
LATEST
-
REGULATORY Revolade, Bilanoa See First Generics in June Listing; 3 Final AGs on Roster
June 11, 2026
-
REGULATORY Official Hints at Potential Change to Growth Target in Draft Roadmap
June 11, 2026
-
BUSINESS Lilly Warns Against Off-Label Use of Mounjaro
June 11, 2026
-
BUSINESS BMS Seeks Japan Approval for Mezigdomide in Multiple Myeloma
June 11, 2026
-
BUSINESS SanBio Sees Akuugo Expanding to 20-30 Treatment Centers
June 11, 2026
-
BUSINESS Rakuten Medical to Promote President Maeda to CEO
June 11, 2026
-
BUSINESS Metagen Starts Global PI/II Trial of Oral FMT Therapy
June 11, 2026
-
BUSINESS Sumitomo Completes Enrollment for Enzomenib PII Analysis
June 11, 2026
-
BUSINESS Takeda's Entyvio IV Under FDA Review for Pediatric Use
June 11, 2026
-
BUSINESS Japan’s First OTC ED Drug Cialis to Hit Shelves in August
June 11, 2026
-
ACADEMIA Urine-Derived Stem Cells Eyed as New Drug Discovery Tool
June 10, 2026
-
REGULATORY Ishin Proposes Adding Drug, Device Makers to Chuikyo, LDP Wary
June 10, 2026
-
REGULATORY Cabinet Approves Immunization Act Revision to Cover Antibody Drugs
June 10, 2026
-
REGULATORY LDP Lawmakers Seek Routine HPV Vaccinations for Males by April 2027
June 10, 2026
-
BUSINESS Healios Countersues AND Medical over Unpaid Milestone
June 10, 2026
-
REGULATORY LDP Team Seeks Minister-Led AI Task Force at MHLW
June 10, 2026
-
REGULATORY MHLW to Continue Reviewing Tavneos Safety Measures: Official
June 10, 2026
-
REGULATORY ONODERA GT’s Parkinson’s Gene Therapy Gets Sakigake Tag
June 10, 2026
-
BUSINESS Moderna Japan Looks Beyond COVID for Next Growth Pillars
June 9, 2026
-
COMMENTARY 20 Years at a Glance: Overseas Sales Surge at Japan Pharma, but R&D Investments Lag
June 9, 2026
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
